Pineal region myeloid sarcoma

Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia
Thomas J WilsonStephen E Sullivan

Abstract

The overwhelming majority of pineal region tumors are malignant germ cell tumors, pineal cell tumors, or glial tumors. To our knowledge we report the first patient with myeloid sarcoma in the pineal region. Myeloid sarcomas are composed of immature granulocytic precursor cells and are associated with acute myelogenous leukemia. Thus, myeloid sarcoma should be considered in the differential diagnosis of pineal region masses in patients with a known history of acute myelogenous leukemia.

References

Dec 15, 1986·Cancer·J M MeisJ T Manning
Mar 1, 1986·AJR. American Journal of Roentgenology·S R GantiP Sane
Sep 1, 1995·Annals of Internal Medicine·K R ImrieA Keating
May 25, 2001·AJR. American Journal of Roentgenology·G C OoiY L Kwong
Dec 24, 2005·Otology & Neurotology : Official Publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology·M Kursat GokcanAhmet I Tataragasi
Sep 20, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Maria Grazia PassarinRebecca Pedersini

❮ Previous
Next ❯

Citations

Jan 15, 2021·World Neurosurgery·Dennis LeeKiarash Shahlaie

❮ Previous
Next ❯

Related Concepts

Related Feeds

AML: Role of LSD1 by CRISPR (Keystone)

Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.